Literature DB >> 20693878

Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner.

Sho-Ya Wang1, Joanna Calderon, Ging Kuo Wang.   

Abstract

BACKGROUND: Duloxetine is a mixed serotonin-norepinephrine reuptake inhibitor used for major depressive disorder. Duloxetine is also beneficial for patients with diabetic peripheral neuropathy and with fibromyalgia, but how it works remains unclear.
METHODS: We used the whole cell, patch clamp technique to test whether duloxetine interacts with the neuronal Nav1.7 Na+ channel as a potential target. Resting and inactivated Nav1.7 Na+ channel block by duloxetine were measured by conventional pulse protocols in transfected human embryonic kidney cells. The open-channel block was determined directly using inactivation-deficient mutant Nav1.7 Na+ channels.
RESULTS: The 50% inhibitory concentration (IC50) of duloxetine for the resting and inactivated wild-type hNav1.7 Na+ channel were 22.1+/-0.4 and 1.79+/-0.10 microM, respectively (mean+/-SE, n=5). The IC50 for the open Na+ channel was 0.25+/-0.02 microM (n=5), as determined by the block of persistent late Nav1.7 Na+ currents. Similar open-channel block by duloxetine was found in the muscle Nav1.4 isoform (IC50=0.51+/-0.05 microM; n=5). Block by duloxetine appeared via the conserved local anesthetic receptor as determined by site-directed mutagenesis. Finally, duloxetine elicited strong use-dependent block of neuronal transient Nav1.7 Na+ currents during repetitive stimulations.
CONCLUSIONS: Duloxetine blocks persistent late Nav1.7 Na+ currents preferentially, which may in part account for its analgesic action.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20693878     DOI: 10.1097/ALN.0b013e3181e89a93

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  19 in total

1.  A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia.

Authors:  Gilberto Vargas-Alarcon; Edith Alvarez-Leon; Jose-Manuel Fragoso; Angelica Vargas; Aline Martinez; Maite Vallejo; Manuel Martinez-Lavin
Journal:  BMC Musculoskelet Disord       Date:  2012-02-20       Impact factor: 2.362

2.  Development of a spontaneously active dorsal root ganglia assay using multiwell multielectrode arrays.

Authors:  Kim Newberry; Shuya Wang; Nina Hoque; Laszlo Kiss; Michael K Ahlijanian; James Herrington; John D Graef
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

Review 3.  Duloxetine, an antidepressant with analgesic properties - a preliminary analysis.

Authors:  Adela Hilda Onuţu
Journal:  Rom J Anaesth Intensive Care       Date:  2015-10

Review 4.  Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Shuiying Hu; Kevin M Huang; Elizabeth J Adams; Charles L Loprinzi; Maryam B Lustberg
Journal:  Clin Cancer Res       Date:  2019-05-23       Impact factor: 12.531

5.  Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes.

Authors:  Takafumi Horishita; Nobuyuki Yanagihara; Susumu Ueno; Dan Okura; Reiko Horishita; Tomoko Minami; Yuichi Ogata; Yuka Sudo; Yasuhito Uezono; Takeyoshi Sata; Takashi Kawasaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-14       Impact factor: 3.000

Review 6.  Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.

Authors:  Nathan P Staff; Guido Cavaletti; Badrul Islam; Maryam Lustberg; Dimitri Psimaras; Stefano Tamburin
Journal:  J Peripher Nerv Syst       Date:  2019-10       Impact factor: 3.494

Review 7.  Multimodal Analgesia, Current Concepts, and Acute Pain Considerations.

Authors:  Erik M Helander; Bethany L Menard; Chris M Harmon; Ben K Homra; Alexander V Allain; Gregory J Bordelon; Melville Q Wyche; Ira W Padnos; Anna Lavrova; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2017-01

8.  A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.

Authors:  T Mixcoatl-Zecuatl; C G Jolivalt
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 9.  Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Grace A Kanzawa-Lee; Robert Knoerl; Clare Donohoe; Celia M Bridges; Ellen M Lavoie Smith
Journal:  Semin Oncol Nurs       Date:  2019-04-30       Impact factor: 2.315

10.  Acute and subacute effects of the selective serotonin-noradrenaline reuptake inhibitor duloxetine on cardiac hERG channels.

Authors:  F Fischer; N Vonderlin; C Seyler; E Zitron; B Schernus; H Katus; E Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-05-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.